Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration

By Reuters News

- Paradigm Biopharmaceuticals Ltd PAR.AX:

  • INITIATES VOLUNTARY ADMINISTRATION PROCESS

  • BOARD INTENDS TO DEVELOP PROPOSAL FOR DEED OF COMPANY ARRANGEMENT

  • SECURITIES REMAIN SUSPENDED FROM TRADING ON ASX DURING ADMINISTRATION

  • CLINICAL REVIEW AND RESTRUCTURING PROCESS EXPECTED TO TAKE AT LEAST EIGHT WEEKS

Further company coverage: PAR.AX

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk